There's effective treatment for opioid addiction. Yet more than a million people aren't getting it.

WHILE BUPRENORPHINE WORKS, CHALLENGES REMAIN.

  • Studies indicate that daily medication compliance is only 72%, which negatively impacts treatment success.

  • Buprenorphine was the most commonly implicated ingredient in emergency hospitalizations of children younger than six from 2007-2011.

We help prescribers improve adherence to buprenorphine treatment, so prescriptions are safer and recovery is more likely.

  • PHARMACY DISPENSING
    Buprenorphine-naloxone in a secure dispenser
  • GUIDES COMPLIANCE
    Promotes a regular pattern of use; "Right Dose, Right Time"
  • TRACKS USAGE AND ENFORCES FLOW CONTROL
    Logs activity and locks to limit rate of access

Research indicates positive effect

graph

A retrospective community treatment cohort study from January 2016 to July 2017 showed preliminary indications of positive outcomes for the MedicaSafe group. Full results forthcoming.

Partners

Icahn School of Medicine at Mount Sinai
Cambridge Health Alliance (MySafeRx)
Veterans Affairs Hospital, Puget Sound

Prescribers face risks and challenges treating with buprenorphine.
Medication compliance is one of them.

SOME FACTS >>

Patient compliance - taking the right dose of prescribed buprenorphine at the right time - predicts better success rates with addiction treatment.

Conversely, poor compliance correlates with heightened risk of illicit opioid use.

Sharing and selling of buprenorphine is commonly reported. So the DEA compels prescribers to track patients carefully and compile detailed records.

All of this contributes to a need for safe, effective prescription monitoring, so treatment can be available to more people.

Contact Us